Procter & Gamble remains a well-managed company but its stock is currently overvalued at 21.15 times its fiscal year 2027 earnings per share, with expected growth of only 1.3%. The company's dividend yield of 2.95% is less attractive compared to risk-free Treasury yields, especially given slowing dividend growth and limited prospects for capital gains. Fiscal 2027 guidance anticipates 1-3% organic sales growth and 1.5% core EPS growth, with significant cost pressures and a first-quarter EPS decline of over 5%. The analyst maintains a neutral stance, preferring a dividend yield above 4% and a price-to-earnings ratio near 15 before considering investment, noting that index funds and Treasuries currently offer better alternatives.
Procter & Gamble (P&G) and Colgate-Palmolive, both Dividend Kings, recently paid dividends with P&G offering a higher yield of 2.93% versus Colgate's 2.33%. P&G's dividend is better covered by earnings and free cash flow, providing a safer and more s...
Procter & Gamble (P&G) and Johnson & Johnson (J&J) both recently increased their long-standing dividends, but P&G's dividend appears more stable due to no planned corporate changes. J&J is preparing a mid-2027 spinoff of its DePuy Synthes unit, which...
The Consumer Staples Select Sector SPDR Fund (XLP) holds many consumer staples stocks but blends very different yield and growth profiles, diluting income potential. Key holdings like Coca-Cola, Procter & Gamble, and Altria offer stronger dividends, ...
Coca-Cola, Johnson & Johnson, and Procter & Gamble have consistently increased their dividends through every U.S. recession since 1970, making them reliable income sources for retirees. These companies boast strong cash flows, solid balance sheets, a...
